Therapeutic and diagnostic targeting of fibrosis in metabolic, proliferative and viral disorders.
Ontology highlight
ABSTRACT: Fibrosis is a common denominator in many pathologies and crucially affects disease progression, drug delivery efficiency and therapy outcome. We here summarize therapeutic and diagnostic strategies for fibrosis targeting in atherosclerosis and cardiac disease, cancer, diabetes, liver diseases and viral infections. We address various anti-fibrotic targets, ranging from cells and genes to metabolites and proteins, primarily focusing on fibrosis-promoting features that are conserved among the different diseases. We discuss how anti-fibrotic therapies have progressed over the years, and how nanomedicine formulations can potentiate anti-fibrotic treatment efficacy. From a diagnostic point of view, we discuss how medical imaging can be employed to facilitate the diagnosis, staging and treatment
SUBMITTER: Sofias AM
PROVIDER: S-EPMC7611899 | biostudies-literature | 2021 Aug
REPOSITORIES: biostudies-literature
ACCESS DATA